Patents by Inventor Hai Yan Hong

Hai Yan Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
    Patent number: 7968081
    Abstract: A peptide for diagnosing, preventing and treating atherosclerosis, and a use thereof, comprising an amino acid sequence as set forth in SEQ ID NO: 1 or SEQ ID NO: 2, and a use thereof. The peptide effectively targets atherosclerotic plaques, and binds to IL-4R to thereby exhibit antagonistic effects on IL-4-mediated signaling of cellular inflammatory reaction and survival reaction. The peptide of the present invention can be used for diagnosis of atherosclerosis, prevention and treatment of IL-4-induced inflammatory reaction and prevention and treatment of atherosclerosis which is primarily caused by the inflammatory reaction, as well as for prevention or treatment of atherosclerosis via conjugation with an anti-atherosclerotic drug.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: June 28, 2011
    Assignee: Kyungpook National University Industry—Academic Cooperation Foundation
    Inventors: Byung Heon Lee, In San Kim, Hai Yan Hong, In Seop So
  • Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
    Publication number: 20090074663
    Abstract: A peptide for diagnosing, preventing and treating atherosclerosis, and a use thereof, comprising an amino acid sequence as set forth in SEQ ID NO: 1 or SEQ ID NO: 2, and a use thereof. The peptide effectively targets atherosclerotic plaques, and binds to IL-4R to thereby exhibit antagonistic effects on IL-4-mediated signaling of cellular inflammatory reaction and survival reaction. The peptide of the present invention can be used for diagnosis of atherosclerosis, prevention and treatment of IL-4-induced inflammatory reaction and prevention and treatment of atherosclerosis which is primarily caused by the inflammatory reaction, as well as for prevention or treatment of atherosclerosis via conjugation with an anti-atherosclerotic drug.
    Type: Application
    Filed: January 18, 2008
    Publication date: March 19, 2009
    Inventors: Byung Heon Lee, In San Kim, Hai Yan Hong, In Seop So